Floatz logo

SODIUM STIBOGLUCONATE ANHYDROUS

Myeloid Malignancy

First Affiliated Hospital of Jinan UniversitySmall moleculePhase 2Dormant
CCC
53/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
38/ 100
Competitive Position
89/ 100

Competitive context

30 Active assets in the Myeloid Malignancy cohort.

Asset / SponsorPhaseRating
Mitoxantrone
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cytosin-Arabinosid
First Affiliated Hospital of Zhejiang University
Phase 3BBB
Cladribine
University of Washington
Phase 2BBB
Cyclophosphamide
Prelude Therapeutics
Phase 3BB
Venetoclax
First Affiliated Hospital of Zhejiang University
Phase 3BB

View all 49 →

Same molecule, other indications

SODIUM STIBOGLUCONATE ANHYDROUS is also rated in:

Sodium StibogluconateDormant
CCC
Indicative ·
53 / 100
View asset →
myelodysplastic syndromeDormant
CCC
Indicative ·
48 / 100
View asset →
metastatic melanomaDormant
CC
Indicative ·
47 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →